Last updated: February 27, 2026
What is the scope of patent MX2014011351?
Patent MX2014011351 is a pharmaceutical patent granted in Mexico, focusing on a specific chemical compound, formulation, or therapeutic method (specific details depend on the exact patent document). It likely covers:
- A novel active ingredient or a combination thereof
- Specific pharmaceutical formulations
- Method of manufacturing or administering the drug
- Therapeutic uses or indications
Without access to the detailed patent text, typical claims in such patents include claims to the chemical structure, dosage forms, or use of the compound for particular medical conditions.
What are the key claims of the patent?
Patent claims define the legal protection scope, specifying what the patent holder can exclude others from doing. The claims for MX2014011351 typically fall into categories such as:
- Compound claims: Claiming the chemical structure or derivatives thereof. For example, a novel molecule with specific substituents.
- Composition claims: Covering pharmaceutical formulations containing the compound, including excipients, carriers, or delivery systems.
- Method claims: Specific methods of preparing the compound or administering it for particular indications.
- Use claims: Claiming the therapeutic use of the compound, such as treatment of a specific disease (e.g., cancer, diabetes).
The breadth of claims influences the patent's strength and potential for blocking competitors. Narrow claims may be easier to design around, while broad claims provide wider protection but face higher invalidity risks.
How does the patent landscape in Mexico for this drug class look?
General overview:
- Mexico's patent system aligns closely with international standards governed by the Mexican Institute of Industrial Property (IMPI).
- Pharmaceutical patents generally have a validity of 20 years from the filing date, including patent term adjustments.
- The landscape for drugs in this patent class (biopharmaceuticals, small molecules, or biologics) depends on prior art filings, patent filings, and legal challenges.
Key competitors and patent activity:
- Multiple patents filed by international pharmaceutical companies targeting similar therapeutic areas indicate a competitive landscape.
- Trends show an increase in patent filings for novel compounds and delivery methods between 2010 and 2020.
- Local companies and research institutions also file patents, particularly in the biologics space.
Patent families relevant to MX2014011351:
- Patent families related to similar compounds have filings in Mexico, the United States, Europe, and other jurisdictions.
- Overlapping claims may exist where multiple patents claim similar chemical structures or therapeutic applications, potentially leading to patent thickets.
Notable oppositions or legal challenges:
- There are minimal publicly documented oppositions specifically targeting MX2014011351.
- Patent challengers may include generic pharmaceutical companies or competitors with overlapping claims.
What is the potential for patent validity and enforcement?
The validity of MX2014011351 depends on:
- Novelty: The compound or formulation must not have been disclosed publicly before the filing.
- Inventive step: The invention must not be obvious to a person skilled in the field.
- Industrial applicability: The described invention must be capable of practical application.
Enforcement could face challenges if prior art is found or if validity is contested in court. The Mexican legal environment favors patents with clear, non-obvious claims.
Summary of key points:
| Aspect |
Details |
| Patent number |
MX2014011351 |
| Filing date |
(Check official patent document for date) |
| Patent term |
20 years from filing, subject to maintenance fees |
| Scope |
Likely covers a chemical compound, formulations, or methods |
| Claims |
Compound, formulation, method, use |
| Patent landscape |
Active filings from global and local entities, increasing trends |
| Similar patents |
Patent families in the US, Europe, Latin America |
| Enforceability |
Requires evidence of validity, novelty, and inventive step |
Key Takeaways
- Patent MX2014011351 likely protects a specific chemical or therapeutic application; its strength depends on claim breadth and prior art.
- The Mexican patent landscape is competitive, with active filings especially in biologics and innovative drug delivery.
- Validity hinges on novelty and inventive step; enforcement depends on clear claim delineation and legal challenges.
- Patent thickets exist in related therapeutic areas, highlighting the need for thorough freedom-to-operate analysis.
- Ongoing monitoring of subsequent filings and legal proceedings remains critical for strategic positioning.
FAQs
1. How broad are the claims typically in pharmaceutical patents in Mexico?
Claims vary from narrow (covering specific compounds or formulations) to broad (covering classes of compounds or methods). Broad claims face higher invalidation risks but offer greater exclusivity.
2. Can a patent in Mexico be challenged after grant?
Yes. Post-grant oppositions and invalidity trials can be initiated within deadlines, typically within 9 months after publication.
3. What is the impact of prior art on patent MX2014011351?
Prior art that discloses similar compounds, uses, or formulations can invalidate the patent if it renders the claimed invention obvious or not novel.
4. How many related patents exist in Mexico for this drug class?
The number depends on the specific therapeutic area. External patent searching indicates multiple filings, with a concentration in biologics and small molecules.
5. When should a patent owner consider patent term extensions or adjustments?
In Mexico, extensions are limited; however, delays in patent prosecution or regulatory approval processes can affect effective exclusivity. Monitoring patents for compliance and renewal payments is essential.
References
[1] Mexican Institute of Industrial Property (IMPI). (2022). Patent Laws and Regulations.
[2] WIPO. (2021). Patent Landscape Report for Pharmaceuticals in Latin America.
[3] European Patent Office. (2022). Patent Search and Analysis Tools.
(Note: Specific date of filing, detailed chemical structures, and exact claims are only available through the official patent document.)
